Back

SGLT2 inhibition: the potential to change the heart failure landscape?

28 August 2017 (13:10 - 13:30)
Organised by:
Congress Presentation Part of: Challenging the current treatment paradigm - SGLT2 inhibition in heart failure (EBAC Accredited) Antiarrhythmic drugs Open Access ESC Congress 2017

About the speaker

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Chair’s introduction - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.
Professor M. Metra (Milan, IT)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure.
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Q&A - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.
Professor M. Metra (Milan, IT) Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Summary & close - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.
Professor M. Metra (Milan, IT)
Slides Video

Access the full session

Session thumbnail
Challenging the current treatment paradigm - SGLT2 inhibition in heart failure (EBAC Accredited)

The Event

Event poster

ESC Congress 2017

28 August 2017 13:10 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources